Correlation Between Phathom Pharmaceuticals and DiaMedica Therapeutics
Can any of the company-specific risk be diversified away by investing in both Phathom Pharmaceuticals and DiaMedica Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phathom Pharmaceuticals and DiaMedica Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Phathom Pharmaceuticals and DiaMedica Therapeutics, you can compare the effects of market volatilities on Phathom Pharmaceuticals and DiaMedica Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phathom Pharmaceuticals with a short position of DiaMedica Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phathom Pharmaceuticals and DiaMedica Therapeutics.
Diversification Opportunities for Phathom Pharmaceuticals and DiaMedica Therapeutics
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Phathom and DiaMedica is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Phathom Pharmaceuticals and DiaMedica Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DiaMedica Therapeutics and Phathom Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phathom Pharmaceuticals are associated (or correlated) with DiaMedica Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DiaMedica Therapeutics has no effect on the direction of Phathom Pharmaceuticals i.e., Phathom Pharmaceuticals and DiaMedica Therapeutics go up and down completely randomly.
Pair Corralation between Phathom Pharmaceuticals and DiaMedica Therapeutics
Given the investment horizon of 90 days Phathom Pharmaceuticals is expected to under-perform the DiaMedica Therapeutics. In addition to that, Phathom Pharmaceuticals is 1.72 times more volatile than DiaMedica Therapeutics. It trades about -0.13 of its total potential returns per unit of risk. DiaMedica Therapeutics is currently generating about 0.19 per unit of volatility. If you would invest 389.00 in DiaMedica Therapeutics on September 3, 2024 and sell it today you would earn a total of 177.00 from holding DiaMedica Therapeutics or generate 45.5% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Phathom Pharmaceuticals vs. DiaMedica Therapeutics
Performance |
| Timeline |
| Phathom Pharmaceuticals |
| DiaMedica Therapeutics |
Phathom Pharmaceuticals and DiaMedica Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Phathom Pharmaceuticals and DiaMedica Therapeutics
The main advantage of trading using opposite Phathom Pharmaceuticals and DiaMedica Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phathom Pharmaceuticals position performs unexpectedly, DiaMedica Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiaMedica Therapeutics will offset losses from the drop in DiaMedica Therapeutics' long position.| Phathom Pharmaceuticals vs. DiaMedica Therapeutics | Phathom Pharmaceuticals vs. Lyra Therapeutics | Phathom Pharmaceuticals vs. Centessa Pharmaceuticals PLC |
| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |